オプションチェーンは、Brookfield Renewableの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Brookfield Renewableの市場センチメントを評価します。.

Brookfield Renewable (NYSE:BEPC) 株価情報, オプションチェーン

Brookfield Renewable

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.

Ordinary Shares - Class A (Exchangeable Sub Voting)

Brookfield Renewable Corporation Brookfield Renewable Corporation Class A Subordinate Voting Shares

Brookfield Renewable Corp

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250512-1478052/1478052_dfs5.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250512-1478052/1478052_dfs5.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250512-1478052/1478052_dfs5.pdf</a>

News

COIN

Coinbase Global Will Replace Discover Financial Services In The S&P 500 Effective Prior To The Opening Of Trading On Monday, May 19

Barclays analyst Lauren Lieberman maintains Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) with a Equal-Weight and raises the price target from $22 to $23.

Price Target

Analyst Ratings

KVUE

Barclays Maintains Equal-Weight on Kenvue, Raises Price Target to $23

Offerings

LQR House Files For Common Stock Offering Of Up To $25M

Barclays analyst Theresa Chen maintains HF Sinclair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) with a Equal-Weight and raises the price target from $29 to $32.

DINO

Barclays Maintains Equal-Weight on HF Sinclair, Raises Price Target to $32

Life360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIF#NASDAQ">LIF</a>) affirms FY2025 sales outlook from $450.00 million-$480.00 million to $450.00 million-$480.00 million vs $466.67 million estimate.

Guidance

Life360 Affirms FY2025 Sales Guidance of $450.00M-$480.00M vs $466.67M Est

Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.09 by 11.11 percent. This is a 20 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $7.74 million which missed the analyst consensus estimate of $9.51 million by 18.66 percent. This is a 40.47 percent decrease over sales of $12.99 million the same period last year.

Earnings

Earnings Misses

CORRECTION: Lument Finance Trust Q1 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $7.74M Miss $9.51M Estimate

MicroVision Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported first-quarter financial results after the market close on Monday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/ac45359368/microvision-announces-first-quarter-2025-results">of the report</a>.
<ul class="wp-block-list">
<li>Q1 Revenue: $589,000, versus <a href="http://benzinga.com/quote/mvis/earnings">estimates</a> of $2.25 million</li>
</ul>
<ul class="wp-block-list">
<li>Q1 Adjusted Loss: 10 cents, versus estimates of seven cents</li>
</ul>
Total operating expenses were down 47% year-over-year to $14.1 million. The company ended the period with $69 million in cash, cash equivalents and investment securities. MicroVision noted that it also has access to $143.4 million of capital through its at-the-market facility and convertible note facility. 
&#8220;MicroVision is well-positioned to secure revenue opportunities for 2025 from the industrial vertical,&#8221; said Sumit Sharma, CEO of MicroVision. &#8220;Our unique value proposition continues to be our integrated perception software. We offer compelling solutions to industrial customers and automotive OEMs at attractive price points.&#8221;
MicroVision said its production commitment with ZF enables the company to commit to high-volume deliveries to fulfill demand in the range of $30 million to $50 million over the next 12 to 18 months. 
The company also highlighted the establishment of a defense industry advisory board in the quarter that aims to accelerate strategic expansion and pursuit of revenue opportunities in the defense tech and military sectors.
Executives are currently discussing the quarter on a conference call that kicked off at 4:30 p.m. ET. The company also plans to hold an Investor Day on May 20. 
MVIS Price Action: <a href="http://benzinga.com/quote/mvis">MicroVision shares</a> were down 15.72% after-hours at 83 cents at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45361467/archer-aviation-reports-smaller-than-expected-loss-in-q1-company-says-uae-launch-remains-on-track-for-2025-shares-surge">Archer Aviation Reports Smaller-Than-Expected Loss In Q1, Company Says UAE Launch Remains &#8216;On Track&#8217; For 2025, Shares Surge</a></li>
</ul>
Photo: courtesy of MicroVision.

Movers

MVIS

MicroVision Stock Tumbles On Q1 Earnings Miss, Company Highlights Industrial Revenue Opportunities, Targets Defense Tech, Military Expansion

CTRI

Centuri Holdings Files For Mixed Shelf Of Up To $500M

ClearPoint Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it has entered into a note financing arrangement with Oberland Capital Management LLC ("Oberland Capital") of up to $105 Million, with $30.0 million of gross proceeds funded at closing. Additional note financing will be provided to the Company by Oberland Capital under the following terms:
An additional $25.0 million at the option of the Company any time prior to December 31, 2026; and
An additional $50.0 million at the option of the Company and Oberland Capital any time prior to December 31, 2026.
In addition to the note financing, the Company entered into a stock purchase agreement with Oberland Capital whereby Oberland Capital purchased 275,808 shares of the Company's common stock at a price of $12.69 per share in a registered direct offering, representing an additional $3,500,003.52 of gross proceeds to the Company. The price per share was equal to the trailing 30-trading days volume-weighted average price for the period ending on the day prior to the date of the stock purchase agreement. Oberland Capital also has the right to participate in a future offering of the Company's common stock in an amount of $1.5 million on or before December 31, 2026.

CLPT

ClearPoint Neuro Secures Up To $105M In Note Financing From Oberland Capital With $30M Funded At Closing, Gains Additional $3.5M Through Direct Stock Sale At $12.69/Share, And Retains Option For $75M More Plus Future $1.5M Equity Participation Through 2026

Barclays analyst Julian Mitchell maintains Regal Rexnord (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRX#NYSE">RRX</a>) with a Overweight and raises the price target from $155 to $160.

Barclays Maintains Overweight on Regal Rexnord, Raises Price Target to $160

Village Farms Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 500 percent. This is a 100 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $77.07 million which beat the analyst consensus estimate of $76.28 million by 1.04 percent. This is a 1.28 percent decrease over sales of $78.08 million the same period last year.

Earnings Beats

Village Farms Intl Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $77.07M Beat $76.28M Estimate

<a href="https://www.bloomberg.com/news/articles/2025-05-12/amc-to-slash-movie-ticket-prices-by-50-on-wednesdays?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-12/amc-to-slash-movie-ticket-prices-by-50-on-wednesdays?embedded-checkout=true</a>

General

'AMC to Slash Movie Ticket Prices by 50% on Wednesdays'- Bloomberg

Barclays analyst Julian Mitchell maintains Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) with a Equal-Weight and raises the price target from $22 to $24.

Barclays Maintains Equal-Weight on Kennametal, Raises Price Target to $24

BSLK

Bolt Projects Holdings Sees FY2026 Revenue To Be At Least $9M

Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) affirms FY2025 sales outlook from $450.00 million-$475.00 million to $450.00 million-$475.00 million vs $462.97 million estimate.

MVST

Microvast Holdings Affirms FY2025 Sales Guidance of $450.00M-$475.00M vs $462.97M Est

Bolt Projects Holdings Sees FY2025 Revenue Of Atleast $4.5M

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 15 years by 12.98% on an annualized basis producing an average annual return of 24.58%. Currently, Copart has a market capitalization of $60.14 billion. 
Buying $100 In CPRT: If an investor had bought $100 of CPRT stock 15 years ago, it would be worth $2,674.99 today based on a price of $62.25 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747084514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CPRT

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Village Farms International Announces Transformative Transaction to Privatize Its Fresh Produce Business; Village Farms' Fresh Segment To Become Cornerstone Of Newco's Commercial Operations And Growth Strategy; Expects To Receive $40M In Cash Proceeds; 37.9% Equity Ownership Interest In Newco; Retains Ownership Of All Canadian Cultivation Assets

Bolt Projects Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) reported quarterly losses of $(3.00) per share. This is a 89.37 percent increase over losses of $(28.22) per share from the same period last year. The company reported $171.00 thousand in sales this quarter. This is a 800.00 percent increase over sales of $19.00 thousand the same period last year.

Bolt Projects Holdings Q1 EPS $(3.00) Up From $(28.22) YoY, Sales $171.00K Up From $19.00K YoY

Central Puerto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEPU#NYSE">CEPU</a>) reported quarterly earnings of $0.50 per share. This is a 150 percent increase over earnings of $0.20 per share from the same period last year. The company reported $196.00 million in sales this quarter. This is a 130.67M percent increase over sales of $150.00 the same period last year.

Comments

Brookfield Renewable

Brookfield Renewable (BEPC) オプション

Brookfield Renewable (NYSE:BEPC) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル